Eagle Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.96M Buy
+54,691
New +$2.57M 0.02% 439
2023
Q4
Sell
-136,917
Closed -$7.95M 563
2023
Q3
$7.95M Sell
136,917
-756
-0.5% -$46.3K 0.05% 293
2023
Q2
$8.8M Buy
137,673
+10,957
+9% +$735K 0.05% 279
2023
Q1
$8.78M Buy
126,716
+5,593
+5% +$394K 0.05% 265
2022
Q4
$8.75M Sell
121,123
-220
-0.2% -$16.6K 0.05% 254
2022
Q3
$8.63M Sell
121,343
-2,211
-2% -$160K 0.06% 255
2022
Q2
$9.51M Sell
123,554
-2,773
-2% -$211K 0.06% 249
2022
Q1
$9.22M Buy
126,327
+1,729
+1% +$116K 0.05% 284
2021
Q4
$7.79M Buy
124,598
+1,320
+1% +$77.4K 0.03% 353
2021
Q3
$7.29M Sell
123,278
-1,346
-1% -$88.6K 0.03% 363
2021
Q2
$8.33M Buy
124,624
+395
+0.3% +$25.8K 0.04% 360
2021
Q1
$7.82M Buy
124,229
+118,796
+2,187% +$7.39M 0.03% 365
2020
Q4
$336K Sell
5,433
-119,892
-96% -$7.37M ﹤0.01% 486
2020
Q3
$7.51M Sell
125,325
-2,482
-2% -$149K 0.04% 319
2020
Q2
$7.39M Buy
127,807
+975
+0.8% +$58.3K 0.04% 317
2020
Q1
$7.07M Buy
126,832
+35,268
+39% +$2.16M 0.04% 319
2019
Q4
$5.88M Buy
+91,564
New +$5.24M 0.03% 387

Other funds holding BMY

Eagle Asset Management's BMY Position: Q3 2024 in Review

Eagle Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2024: 54,691 shares worth $2.96M. The stake represents 0.02% of the portfolio and ranks #439 among its holdings. This is a return to the name: Eagle Asset Management previously reported a position in BMY as recently as Q3 2023.

Eagle Asset Management first reported a position in BMY in Q4 2019 and has held it in 17 quarters since. The position peaked at $9.51M in Q2 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Eagle Asset Management held 54,691 shares of Bristol-Myers Squibb worth $2.96M as of Q3 2024.
  • Bristol-Myers Squibb was a new Eagle Asset Management position in Q3 2024.
  • Bristol-Myers Squibb made up 0.02% of Eagle Asset Management's portfolio in Q3 2024, its #439 holding.
  • Eagle Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 17 quarters since.
  • Eagle Asset Management's Bristol-Myers Squibb position peaked at $9.51M in Q2 2022.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.